These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 8155865)

  • 1. Anti-neutrophil cytoplasmic antibody: a prognostic indicator in primary sclerosing cholangitis.
    Pokorny CS; Norton ID; McCaughan GW; Selby WS
    J Gastroenterol Hepatol; 1994; 9(1):40-4. PubMed ID: 8155865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutrophil antibodies (pANCA) in chronic liver disease and inflammatory bowel disease: do they react with different antigens?
    Seibold F; Weber P; Schöning A; Mörk H; Goppel S; Scheurlen M
    Eur J Gastroenterol Hepatol; 1996 Nov; 8(11):1095-100. PubMed ID: 8944372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutrophil autoantibodies: a genetic marker in primary sclerosing cholangitis and ulcerative colitis.
    Seibold F; Slametschka D; Gregor M; Weber P
    Gastroenterology; 1994 Aug; 107(2):532-6. PubMed ID: 8039629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Segregation of pANCA antigenic recognition by DNase treatment of neutrophils: ulcerative colitis, type 1 autoimmune hepatitis, and primary sclerosing cholangitis.
    Vidrich A; Lee J; James E; Cobb L; Targan S
    J Clin Immunol; 1995 Nov; 15(6):293-9. PubMed ID: 8576315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of antibodies against neutrophils in patients with inflammatory bowel disease and primary sclerosing cholangitis.
    Seibold F; Weber P; Klein R; Berg PA; Wiedmann KH
    Gut; 1992 May; 33(5):657-62. PubMed ID: 1612483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antineutrophil antibodies define clinical and genetic subgroups in primary sclerosing cholangitis.
    Hov JR; Boberg KM; Taraldsrud E; Vesterhus M; Boyadzhieva M; Solberg IC; Schrumpf E; Vatn MH; Lie BA; Molberg Ø; Karlsen TH
    Liver Int; 2017 Mar; 37(3):458-465. PubMed ID: 27558072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of anti-neutrophil antibody in primary sclerosing cholangitis and ulcerative colitis using an alkaline phosphatase technique.
    Lo SK; Fleming KA; Chapman RW
    Gut; 1992 Oct; 33(10):1370-5. PubMed ID: 1446862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutrophil cytoplasmic autoantibodies after liver transplantation in patients with primary sclerosing cholangitis.
    Haagsma EB; Mulder AH; Gouw AS; Horst G; Meerman L; Slooff MJ; Kallenberg CG
    J Hepatol; 1993 Aug; 19(1):8-14. PubMed ID: 8301047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Importance of antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis and ulcerative colitis: prevalence, titre, and IgG subclass.
    Bansi DS; Fleming KA; Chapman RW
    Gut; 1996 Mar; 38(3):384-9. PubMed ID: 8675091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoantibodies to beta tubulin in autoimmune liver diseases-Relation to pANCA and clinical relevance.
    Preuß B; Frank A; Terjung B; Spengler U; Berg C; Klein R
    Clin Exp Immunol; 2024 Apr; 216(2):146-158. PubMed ID: 37823420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoantibody profile of primary sclerosing cholangitis.
    Gur H; Shen G; Sutjita M; Terrberry J; Alosachie I; Barka N; Lin HC; Peter JB; Meroni PL; Kaplan M
    Pathobiology; 1995; 63(2):76-82. PubMed ID: 8554703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antineutrophil cytoplasmic autoantibodies in autoimmune liver and inflammatory bowel diseases.
    Claise C; Johanet C; Bouhnik Y; Kapel N; Homberg JC; Poupon R
    Liver; 1996 Feb; 16(1):28-34. PubMed ID: 8868075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutrophil cytoplasmic antibodies: a link between primary sclerosing cholangitis and ulcerative colitis.
    Duerr RH; Targan SR; Landers CJ; LaRusso NF; Lindsay KL; Wiesner RH; Shanahan F
    Gastroenterology; 1991 May; 100(5 Pt 1):1385-91. PubMed ID: 2013383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-neutrophil cytoplasmic antibodies (ANCA) specific for one or several antigens: useful markers for subtypes of ulcerative colitis and associated primary sclerosing cholangitis.
    Dobric S; Popovic D; Nikolic M; Andrejevic S; Spuran M; Bonaci-Nikolic B
    Clin Chem Lab Med; 2011 Nov; 50(3):503-9. PubMed ID: 22107137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IgA class antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis and autoimmune hepatitis.
    Schwarze C; Terjung B; Lilienweiss P; Beuers U; Herzog V; Sauerbruch T; Spengler U
    Clin Exp Immunol; 2003 Aug; 133(2):283-9. PubMed ID: 12869036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contrasting Pattern of Chronic Inflammatory Bowel Disease in Primary and Autoimmune Sclerosing Cholangitis.
    Bjarnason I; Hayee B; Pavlidis P; Kvasnovsky C; Scalori A; Sisson G; Charlesworth A; Shaikh H; Bjornsson E; Heneghan MA
    EBioMedicine; 2015 Oct; 2(10):1523-7. PubMed ID: 26629548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and characterization of neutrophil cytoplasmic antibodies in autoimmune liver diseases.
    Mulder AH; Horst G; Haagsma EB; Limburg PC; Kleibeuker JH; Kallenberg CG
    Hepatology; 1993 Mar; 17(3):411-7. PubMed ID: 8444414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic role.
    Quinton JF; Sendid B; Reumaux D; Duthilleul P; Cortot A; Grandbastien B; Charrier G; Targan SR; Colombel JF; Poulain D
    Gut; 1998 Jun; 42(6):788-91. PubMed ID: 9691915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antineutrophil cytoplasmic antibodies in bile are associated with disease activity in primary sclerosing cholangitis.
    Lenzen H; Weismüller TJ; Negm AA; Wlecke J; Loges S; Strassburg CP; Manns MP; Lankisch TO
    Scand J Gastroenterol; 2013 Oct; 48(10):1205-12. PubMed ID: 23957616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antineutrophil cytoplasmic antibody in inflammatory bowel and hepatobiliary diseases. High prevalence in ulcerative colitis, primary sclerosing cholangitis, and autoimmune hepatitis.
    Hardarson S; Labrecque DR; Mitros FA; Neil GA; Goeken JA
    Am J Clin Pathol; 1993 Mar; 99(3):277-81. PubMed ID: 8447289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.